{"id":"W2165741055","doi":"10.1093/annonc/mdp233","title":"Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":534,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research; Roche","keywords":"Medicine; Bevacizumab; Irinotecan; Oxaliplatin; Internal medicine; Capecitabine; FOLFOX; FOLFIRI; Colorectal cancer; Oncology; Fluorouracil; Surgery; Chemotherapy; Chemotherapy regimen; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179219,0.0006435963,0.002142747,0.0004279369,0.0002984489,0.0007785952,0.0006955317,0.001108158,0.001238403],"category_scores_gemma":[0.002783928,0.0003472746,0.002179345,0.0005055683,0.0005470341,0.001169418,0.000326214,0.002361152,0.0002376299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001135545,"about_ca_system_score_gemma":0.0008480404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001105275,"about_ca_topic_score_gemma":0.002032244,"domain_scores_codex":[0.999024,0.0004299177,0.00005813111,0.0001589957,0.0002019266,0.0001269973],"domain_scores_gemma":[0.9981389,0.000549062,0.0006055198,0.0001586954,0.0001021741,0.0004455423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8576065,0.009757062,0.03449557,0.0005276633,0.005052278,0.000115152,0.0001022012,0.00148933,0.005463339,0.0001295512,0.0009465314,0.08431491],"study_design_scores_gemma":[0.2451988,0.5486308,0.1897037,0.0001227317,0.00685022,0.0005941786,0.0001088677,0.002458547,0.002790892,0.0004005748,0.003051642,0.00008897481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994272,0.004516724,0.0001122766,0.0001228157,0.00004985733,0.00006978438,0.0002978658,0.00001324226,0.0005455036],"genre_scores_gemma":[0.9970354,0.001240729,0.0001704241,0.0001883052,0.0001650393,0.00006156244,0.0006157867,0.00000855972,0.0005141836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002179219,"threshold_uncertainty_score":0.01152498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05728466980328281,"score_gpt":0.3809595963763208,"score_spread":0.323674926573038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}